uniQure N.V. announced the appointment of Ricardo Dolmetsch, Ph.D., as President, Research and Development, effective September 14, 2020. Dr. Dolmetsch will succeed Sander van Deventer, M.D., Ph.D, Executive Vice President, Research and Product Development. Robert Gut, M.D., Ph.D., will move from his role as Chief Medical Officer after a transition period following the start of Dr. Dolmetsch’s employment, and the Company plans for Dr. Gut to continue to serve on the Board of Directors. Dr. Dolmetsch joins uniQure from Novartis Institutes for Biomedical Research (NIBR), the research arm of Novartis AG, where he served as the Global Head of Neuroscience since 2013.